Biomea Fusion financials
$1.26−2.33%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — |
| Operating income | -$83.5M | -$144.1M | -$126.1M | -$83.6M | -$41.7M |
| Net income | -$61.8M | -$138.4M | -$117.3M | -$81.8M | -$41.6M |
| Net margin | — | — | — | — | — |
| Diluted EPS | $-1.18 | $-3.83 | $-3.44 | $-2.80 | $-1.74 |
| EBITDA | -$79.9M | -$142.3M | -$124.6M | -$82.9M | -$41.4M |
| Operating cash flow | -$70.4M | -$119.9M | -$96.6M | -$62.4M | -$35.4M |
| Free cash flow | -$70.4M | -$120.3M | -$100.0M | -$63.4M | -$38.6M |
| Diluted shares | 52.2M | 36.1M | 34.1M | 29.3M | 23.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $55.8M | $58.3M | $176.9M | $111.9M | $145.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $1.1M | $27.8M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $58.6M | $79.9M | $199.9M | $129.3M | $185.7M |
| Total liabilities | $29.0M | $28.4M | $30.7M | $20.8M | $6.9M |
| Shareholders' equity | $29.6M | $51.6M | $169.2M | $108.5M | $178.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology